Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and benomyl

3,4-dihydroxyphenylacetaldehyde has been researched along with benomyl in 2 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)
Trials
(3,4-dihydroxyphenylacetaldehyde)
Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)
Studies
(benomyl)
Trials
(benomyl)
Recent Studies (post-2010) (benomyl)
99050529164

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnhill, L; Bronstein, JM; Casida, JE; Cockburn, M; Fitzmaurice, AG; Lam, HA; Lulla, A; Maidment, NT; Murphy, NP; O'Donnell, KC; Rhodes, SL; Ritz, B; Sagasti, A; Stahl, MC1
Casida, JE; Cooney, A; Ford, B; Goldstein, DS; Jinsmaa, Y; Sullivan, P1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and benomyl

ArticleYear
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Jan-08, Volume: 110, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Benomyl; Dopaminergic Neurons; Flow Cytometry; Fungicides, Industrial; Humans; Logistic Models; Mesencephalon; Mitochondria; Nerve Degeneration; Odds Ratio; Parkinson Disease; Rats; Zebrafish

2013
Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
    Chemical research in toxicology, 2014, Aug-18, Volume: 27, Issue:8

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Aldehydes; Animals; Antifungal Agents; Benomyl; Cell Line; Enzyme Inhibitors; Humans; Lipid Peroxidation; Mice; Parkinson Disease; PC12 Cells; Rats

2014